Ivrea Pharmaceuticals

PharmaceuticalsSeries AQuincy, US

Latest round

Series A

Last raised

Jun 2005

Total raised

$3M

Investors

2

About Ivrea Pharmaceuticals

Ivrea Pharmaceuticals is a US-based pharmaceutical company that operates as a provider of clinical development and commercialization of prescription pharmaceuticals for the treatment of dermatologic conditions, such as onychomychosis, acne, and photodamage.

Who invested in Ivrea Pharmaceuticals

2 investors across 1 round

See all investors in Ivrea Pharmaceuticals

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Jun 27, 2005

    Amount

    $3M

    Investors

    Locked

Questions about Ivrea Pharmaceuticals

Who invested in Ivrea Pharmaceuticals?

Ivrea Pharmaceuticals has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Ivrea Pharmaceuticals raised?

Ivrea Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Ivrea Pharmaceuticals last raise money?

Ivrea Pharmaceuticals's most recent round on record is a Series A, in Jun 2005.

What does Ivrea Pharmaceuticals do?

Ivrea Pharmaceuticals is a US-based pharmaceutical company that operates as a provider of clinical development and commercialization of prescription pharmaceuticals for the treatment of dermatologic conditions, such as onychomychosis, acne, and photodamage.

Where is Ivrea Pharmaceuticals headquartered?

Ivrea Pharmaceuticals is headquartered in Quincy, US.

Which VCs invest in companies like Ivrea Pharmaceuticals?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Ivrea Pharmaceuticals's stage. Their profiles are linked below.

Raising like Ivrea Pharmaceuticals? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.